miR-200b regulates cellular senescence and inflammatory responses by targeting ZEB2 in pulmonary emphysema
Source abstract
Abstract
Smoking is an important factor in the pathogenesis of chronic obstructive pulmonary disease (COPD), which is commonly characterised by cellular senescence and inflammation. Recently, miR-200b has emerged as an important target to cure lung disease; however, the function of miR-200b in reducing cellular senescence and inflammatory responses has not been reported. In this study, we found that miR-200b was downregulated in the lungs of COPD model mice, and its expression is correlated with cellular senescence and inflammatory responses. We hypothesised that miR-200b may be a potential novel therapy for treating COPD. We performed senescence-Associated-β-galactosidase (SA-β-GAL) staining, western blot, qRT-PCR and ELISA; our data suggested that miR-200b is an anti-aging factor in the lungs that is involved in inflammatory responses. We also confirmed that ZEB2 (Zinc finger E-box binding homeobox 2) is a target gene of miR-200b using luciferase reporter assay. In addition, we verified the function of ZEB2 in cellular senescence and inflammatory responses through transfection experiments. Moreover, we found that the protective effects of miR-200b are inhibited when cells overexpress the ZEB2 protein. In conclusion, our results suggest that miR-200b may attenuate cellular senescence and inflammatory responses by targeting ZEB2 in pulmonary emphysema.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: MicroRNA in disease regulation · Neonatal Respiratory Health Research · Telomeres, Telomerase, and Senescence
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Cardiovascular Surgery, First Affiliated Hospital of Anhui Medical University
Department of Anesthesiology, Drum Tower Hospital, Medical College of Nanjing University
Department of Radiation Oncology, First Hospital of Jilin University
Department of Cardiac Intensive Care Unit, First Affiliated Hospital of Anhui Medical University
Funding
Natural Foundation of Anhui Province
References (26)
Show source-provided references
1. 10.1172/JCI6013210.1172/JCI60132 ↗
2. 10.1165/rcmb.2016-0198OC10.1165/rcmb.2016-0198OC ↗
3. 10.18632/oncotarget.1511610.18632/oncotarget.15116 ↗
4. 10.1016/j.cell.2017.07.04910.1016/j.cell.2017.07.049 ↗
5. 10.1038/nrd.2016.24610.1038/nrd.2016.246 ↗
6. 10.1038/cdd.2011.4210.1038/cdd.2011.42 ↗
7. 10.1016/j.it.2019.03.00110.1016/j.it.2019.03.001 ↗
8. 10.1080/15384101.2017.141770810.1080/15384101.2017.1417708 ↗
9. 10.1016/j.toxlet.2019.07.02110.1016/j.toxlet.2019.07.021 ↗
10. 10.1016/j.toxlet.2018.03.01010.1016/j.toxlet.2018.03.010 ↗
11. 10.1007/s40265-019-01186-x10.1007/s40265-019-01186-x ↗
12. 10.1007/s10753-018-0761-310.1007/s10753-018-0761-3 ↗
13. Yongtao Xiao WY, Lu L, Wang Y, et al. Wei Cai: p38 p53 miR 200a 3p feedback loop promotes oxidative stress-mediated liver cell death. Cell Cycle. 2015;10:10.
14. 10.1002/jat.315710.1002/jat.3157 ↗
15. 10.1002/hep.2915310.1002/hep.29153 ↗
16. 10.3390/cells708008610.3390/cells7080086 ↗
17. 10.1183/16000617.0040-201710.1183/16000617.0040-2017 ↗
18. 10.1111/bph.1351810.1111/bph.13518 ↗
19. 10.1074/mcp.RA118.00096110.1074/mcp.RA118.000961 ↗
20. 10.15252/embj.20179878610.15252/embj.201798786 ↗
21. 10.1038/onc.2016.3110.1038/onc.2016.31 ↗
22. 10.1038/nri91010.1038/nri910 ↗
23. 10.1016/j.ajpath.2017.08.02710.1016/j.ajpath.2017.08.027 ↗
24. 10.1248/bpb.b19-0017410.1248/bpb.b19-00174 ↗
25. 10.1038/s41590-019-0449-310.1038/s41590-019-0449-3 ↗
26. 10.1158/0008-5472.CAN-14-011010.1158/0008-5472.CAN-14-0110 ↗